AIP
HRMY icon

Ameritas Investment Partners’s Harmony Biosciences HRMY Stock Holding History

Ameritas Investment Partners’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$149K Buy
4,100
+446
+12% +$14.1K ﹤0.01% 1587
2026
Q1 		$102K Hold
3,654
– – ﹤0.01% 1688
2025
Q4 		$137K Hold
3,654
– – ﹤0.01% 1508
2025
Q3 		$101K Sell
3,654
-812
-18% -$28K ﹤0.01% 1688
2025
Q2 		$141K Buy
4,466
+479
+12% +$15.4K ﹤0.01% 1508
2025
Q1 		$132K Hold
3,987
– – ﹤0.01% 1517
2024
Q4 		$137K Buy
3,987
+1,029
+35% +$35.4K ﹤0.01% 1571
2024
Q3 		$118K Hold
2,958
– – ﹤0.01% 1678
2024
Q2 		$89.2K Sell
2,958
-320
-10% -$9.62K ﹤0.01% 1804
2024
Q1 		$110K Hold
3,278
– – ﹤0.01% 1671
2023
Q4 		$106K Hold
3,278
– – ﹤0.01% 1695
2023
Q3 		$107K Buy
3,278
+554
+20% +$19.2K ﹤0.01% 1603
2023
Q2 		$95.9K Buy
2,724
+757
+38% +$26.1K ﹤0.01% 1625
2023
Q1 		$64.2K Hold
1,967
– – ﹤0.01% 1819
2022
Q4 		$96.5K Hold
1,967
– – ﹤0.01% 1627
2022
Q3 		$87K Hold
1,967
– – ﹤0.01% 1594
2022
Q2 		$95K Buy
1,967
+214
+12% +$9.63K ﹤0.01% 1545
2022
Q1 		$85K Hold
1,753
– – ﹤0.01% 1750
2021
Q4 		$75K Hold
1,753
– – ﹤0.01% 1859
2021
Q3 		$67K Hold
1,753
– – ﹤0.01% 1961
2021
Q2 		$49K Buy
1,753
+1,233
+237% +$37K ﹤0.01% 2202
2021
Q1 		$17K Hold
520
– – ﹤0.01% 2630
2020
Q4 		$19K Buy
+520
New +$21K ﹤0.01% 2497

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ameritas Investment Partners's HRMY Position: Q2 2026 in Review

Ameritas Investment Partners increased its Harmony Biosciences (HRMY) stake by 12% in Q2 2026, buying an estimated $14.1K and bringing the position to 4,100 shares worth $149K. The position accounts for ﹤0.01% of the portfolio, ranked #1587.

Ameritas Investment Partners first reported a position in HRMY in Q4 2020 and has held it in 23 quarters since. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Ameritas Investment Partners held 4,100 shares of Harmony Biosciences worth $149K as of Q2 2026.
  • Ameritas Investment Partners bought 446 Harmony Biosciences shares in Q2 2026, an estimated $14.1K.
  • Harmony Biosciences made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #1587 holding.
  • Ameritas Investment Partners first reported a position in Harmony Biosciences in Q4 2020 and has held it in 23 quarters since.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.